CCT - Crypto Currency Tracker logo CCT - Crypto Currency Tracker logo
crypto.news 2025-01-22 21:08:10

CME could launch SOL and XRP futures on Feb. 10

The CME’s staging website indicated that investors could soon access futures contracts for Solana and Ripple’s XRP. Solana ( SOL ) and Ripple ( XRP ) futures trading is set to debut on the Chicago Mercantile Exchange platform on Feb. 10, according to a supposed CME subdomain . Bloomberg exchange-traded fund analyst, Eric Balchunas, noted that the update appeared on the “beta.cmegroup” website, which stated that the two products were pending regulatory approval. Fellow ETF expert James Seyffart also emphasized that the news wasn’t shared via official channels, advising caution until the exchange posts confirmation. “Honestly, if this is fake, it’s a pretty good fakeout. I’m waiting for CME to officially confirm this via press release or their actual website though,” Seyffart wrote on X. Assuming "beta.cmegroup" is actually a beta/test version of the actual CMEGroup website — looks like CME is expecting to launch SOL & XRP futures on Feb 10. But this isn't available on the actual website yet. Honestly makes sense and largely to be expected if true IMO https://t.co/lfMGd8X9KE — James Seyffart (@JSeyff) January 22, 2025 You might also like: Local media refutes Ledger CEO kidnap speculation Several financial juggernauts, including JPMorgan and Standard Chartered, believe that more ETFs will go live in 2025. Analysts have predicted up to $14 billion in new cash flow into SOL and XRP products if regulators give the green light. Issuers have filed documents with the Securities and Exchange Commission to bring these products to market, although roadblocks emerged last year. Industry sentiment suggests that regulatory clarity over SOL’s security status will be a deciding factor. However, optimism remains due to a new pro-crypto administration expected under President Donald Trump. Read more: Lido co-founder hints at second Ethereum Foundation

Read the Disclaimer : All content provided herein our website, hyperlinked sites, associated applications, forums, blogs, social media accounts and other platforms (“Site”) is for your general information only, procured from third party sources. We make no warranties of any kind in relation to our content, including but not limited to accuracy and updatedness. No part of the content that we provide constitutes financial advice, legal advice or any other form of advice meant for your specific reliance for any purpose. Any use or reliance on our content is solely at your own risk and discretion. You should conduct your own research, review, analyse and verify our content before relying on them. Trading is a highly risky activity that can lead to major losses, please therefore consult your financial advisor before making any decision. No content on our Site is meant to be a solicitation or offer.